This update was written automatically with AI from market data and news wire reports, and published without review by a person.
Key Takeaways
- Energy prices skyrocketed with Brent crude settling 4.00% higher at $113.17/bbl and U.S. crude up 2.39% to $99.47/bbl amid reports of potential military strikes on Iran.
- Moderna (MRNA) shares plummeted 14.3%, wiping out $12 billion in market value following an unauthorized leak of Phase 3 cancer vaccine data.
- Geopolitical uncertainty intensified as Lebanon-Israel talks in Florida ended without a breakthrough, and Vladimir Putin labeled Eastern Ukraine "historically Russian land."
- SpaceX’s Starlink faced renewed scrutiny as U.S. lawmakers demanded an inquiry into connectivity restrictions affecting Ukrainian defense operations.
- Merck (MRK) reported that its combination therapy with Moderna significantly reduced the risk of melanoma recurrence or death by 42% in a pivotal Phase 3 trial.
Energy Markets and Geopolitical Volatility
Global energy benchmarks surged on Thursday as traders reacted to escalating Middle East tensions and reports of potential military action involving Iran. Brent crude futures settled at $113.17 per barrel, a gain of $4.35, while U.S. West Texas Intermediate (WTI) rose 2.39% to settle at $99.47. The rally was fueled by reports suggesting the U.S. and Israel may consider strikes on Iranian targets following the upcoming November elections, alongside a 3.1 million barrel drop in U.S. commercial crude inventories.
In Florida, U.S.-mediated technical military talks between Lebanon and Israel concluded at CENTCOM headquarters without a breakthrough. Disagreements over monitoring mechanisms and Israel's refusal to halt military operations in southern Lebanon remain primary obstacles. Simultaneously, Russian President Vladimir Putin reiterated claims that Eastern Ukraine is "historically Russian land," though he maintained that Russia is not preparing for a broader war with Europe.
Biotech Turmoil: Moderna and Merck
Shares of Moderna (MRNA) experienced a violent reversal, tumbling 14.3% to close at $205.67 after hitting a 52-week high just a day prior. The selloff was triggered by an unauthorized publication of Phase 3 results for its personalized mRNA cancer vaccine, intismeran, which is being developed in partnership with Merck (MRK). Despite the chaotic disclosure, the data from the INTerpath-001 trial was clinically positive, showing the combination with Keytruda reduced the risk of recurrence or death by 42% compared to Keytruda alone.
Merck (MRK) confirmed the safety profile of the combination was consistent with previous studies, with no new safety signals observed. While the clinical results mark a "landmark moment" for mRNA-based cancer therapy, the market's reaction focused on the breach of embargo and aggressive institutional selling.
Technology and Defense: The Starlink Controversy
SpaceX founder Elon Musk and the Starlink satellite network are under fire from U.S. lawmakers following reports of connectivity restrictions in Ukraine. The restrictions, which reportedly capped speeds for equipment traveling over 100 mph, have disrupted Ukrainian drone and missile interceptor operations. Vice President JD Vance defended Musk, shifting blame to European nations for their reliance on American technology while criticizing U.S. policy for failing to provide clear guidance to private contractors in active war zones.
Monetary Policy and Commodities
The European Central Bank (ECB) is widely expected to hold interest rates steady at its October meeting, with analysts forecasting a final hike in December. Rising bond yields, particularly in France, are already tightening financial conditions, potentially allowing the central bank to pause its tightening cycle.
In the commodities space, gold prices declined to approximately $4,084 per ounce, a two-month low. The drop occurred despite record central bank purchases—estimated by Goldman Sachs at 79 tonnes in August—as rising oil prices and persistent inflation fears led investors to expect the Federal Reserve will keep interest rates elevated for longer.
AI Standards and Innovation
In the technology sector, Anthropic announced it has donated the Agent Skills open standard to the Agentic AI Foundation (AAIF). This move, supported by the Linux Foundation, aims to establish vendor-neutral standards for how AI agents gain new capabilities. The donation includes the Agent Skills name, logo, and GitHub organization, reinforcing a community-driven roadmap for the development of agentic AI.
Automated market updates written with AI from market data and news wire reports, published without human review.